Atlas Trials

Coadministration of Measles-rubella and Rotavirus Vaccines

Clinical trial NCT01700621 · COMPLETED

Trial details

NCT number
NCT01700621
Sponsor
PATH
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Measles Antibody SeroconversionRubella Antibody SeroconversionRotavirus Geometric Mean Titer (GMT)Rotavirus Immunoglobulin A (IgA) Seropositivity
Start date
2013-01-01
Primary completion
2013-09-01
Enrollment
482

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.